Category Matches
- 0.1 mg
- 1 g
- 1 kg
- 1 kit
- 1 L
- 1 mg
- 1 ml
- 1 MU
- 1 Plate
- 1 µg
- 10 g
- 10 mg
- 10 ml
- 10 µg
- 100 g
- 100 mg
- 100 mh
- 100 ml
- 100 Tests
- 100 µg
- 100-200 Tests
- 1000 g
- 100g
- 11β-HSD Inhibitor
- 125 mg
- 125 Tests
- 1mg
- 2 Plates
- 4 Plates
- 4 vial Pack
- 5 Plates
- 5 x 100 µg
- 5-HT1 Receptors - Analgesics
- 5-HT1 Receptors - Antidepressant
- 5-HT1 Receptors - Antipsychotic
- 5-HT1 Receptors - Anxiolytic
- 5-HT1 Receptors - Cognition Enhancing
- 5-HT1 Receptors - Hypnotics
- 5-HT1 Receptors - Sedatives
- 5-HT2 Receptors - Analgesics
- 5-HT2 Receptors - Antidepressant
- 5-HT2 Receptors - Antipsychotic
- 5-HT2 Receptors - Anxiolytic
- 5-HT2 Receptors - Cognition Enhancing
- 5-HT2 Receptors - Hypnotics
- 5-HT2 Receptors - Neurodegenerative Diseases
- 5-HT2 Receptors - Sedatives
- 5-HT3 Receptors - Analgesics
- 5-HT3 Receptors - Antidepressant
- 5-HT3 Receptors - Antipsychotic
- 5-HT3 Receptors - Anxiolytic
- 5-HT3 Receptors - Cognition Enhancing
- 5-HT3 Receptors - Hypnotics
- 5-HT3 Receptors - Sedatives
- 5-HT5 Receptors - Analgesics
- 5-HT5 Receptors - Antidepressant
- 5-HT5 Receptors - Antipsychotic
- 5-HT5 Receptors - Anxiolytic
- 5-HT5 Receptors - Cognition Enhancing
- 5-HT5 Receptors - Neurodegenerative Diseases
- 5-HT5 Receptors - Sedatives
- 5-HT6 Receptors - Analgesics
- 5-HT6 Receptors - Antidepressant
- 5-HT6 Receptors - Antipsychotic
- 5-HT6 Receptors - Anxiolytic
- 5-HT6 Receptors - Cognition Enhancing
- 5-HT6 Receptors - Neurodegenerative Diseases
- 5-HT6 Receptors - Sedatives
- 5-HT7 Receptors - Analgesics
- 5-HT7 Receptors - Antidepressant
- 5-HT7 Receptors - Antipsychotic
- 5-HT7 Receptors - Anxiolytic
- 5-HT7 Receptors - Cognition Enhancing
- 5-HT7 Receptors - Sedatives
- 5-Lipoxygenase Inhibitors
- 50-100 Tests
- 6-hydroxydopamine
- acepromazine
- ACP-196
- ACP196
- Adenosine Receptors - Analgesics
- Adenosine Receptors - Antiepileptics and Anticonvulsants
- Adenosine Receptors - Anxiolytic
- Adenosine Receptors - Cognition Enhancing
- Adenosine Receptors - Neurodegenerative Diseases
- Adenosine Receptors - Sedatives
- Adrenergic Receptors - Analgesics
- Adrenergic Receptors - Anesthetic
- Adrenergic Receptors - Antidepressant
- Adrenergic Receptors - Antiepileptics and Anticonvulsants
- Adrenergic Receptors - Antipsychotic
- Adrenergic Receptors - Anxiolytic
- Adrenergic Receptors - Cognition Enhancing
- Adrenergic Receptors - Hypnotics
- Adrenergic Receptors - Neurodegenerative Diseases
- Adrenergic Receptors - Sedatives
- adu-s100
- adus100
- Aldosterone and ENaC Antagonists (K+ Sparing diuretics)
- Aldosterone Antagonists - Antihypertensive
- allopurinol
- alpha-zearalanol
- alpha-zearalenol
- Amoxapine
- AMPA - Analgesics
- AMPA - Antipsychotic
- AMPA - Anxiolytic
- AMPA - Cognition Enhancing
- AMPA - Neurodegenerative Diseases
- AMPA - Sedatives
- amphenicols
- Amphibian peptides and Hormones
- AMPK
- AMPK - Cognition Enhancing
- AMPK - Neurodegenerative Diseases
- AMPs
- Amyotrophic Lateral Sclerosis
- Analgesics and Antinociceptives
- Androgen Receptor Modulators
- andrographolide
- Anti-osteoporotics
- Anti-parasitic
- Anti-parasitic
- Anti-protozoal
- Anti-pruritics
- Anti-psoriatics
- Anti-resorptives
- Antidepressant
- Antiepileptics and Anticonvulsants
- Antihistamines - Therapies for Respiratory Diseases and Allergy Management
- Antihyperlipidemics
- Antihypertensive
- Antimicrobial - Peptides
- Antimicrobial Peptides - Microbiology
- Antimicrobial Peptides - Natural Products
- Antimicrobial Peptides - Others
- Antiplatelet Compounds
- Antiprogestogens
- Antipropulsives
- Antipsychotic
- Apicidin
- Apitolisib
- Appetite Modulators
- Arthropod peptides and Hormones
- AT-7519
- AT7519
- AZ-5104
- AZ5104
- AZD-1152
- AZD-1152-HQPA
- AZD-1208
- AZD-8186
- AZD-9291
- BACE1
- BAY1816032
- Beta-Adrenergic Receptor Antagonists
- Bisphosphonates
- BIX01294
- Blog Post
- BMP
- boceprevir
- BUB1
- BYL719
- Ca2+ Channel Blockers - Antihypertensive
- Ca2+ Channels - Antidepressant
- Ca2+ Channels - Antiepileptics and Anticonvulsants
- Ca2+ Channels - Antipsychotic
- Ca2+-sensing Receptors - Neurodegenerative Diseases
- Cannabinoid Receptors - Analgesics
- Cannabinoid Receptors - Antidepressant
- Cannabinoid Receptors - Anxiolytic
- Cannabinoid Receptors - Sedatives
- capecitabine
- capsaicin
- Captopril
- carbamazepine
- carbapenems
- Cardioprotective
- CCK Receptor Antagonists
- cecropin
- CEP-28122
- cephalosporins
- cgamp
- chemicals for COVID-19 research
- Chemopreventive
- CHIR99021
- Chk1/2
- Chloramphenicol
- chlorpheniramine
- cisplatin
- cloxazepine
- clozapine
- compound c
- Compounds targeting DNA synthesis and repair
- Contraceptives
- copanlisib
- Corticotropin
- Corticotropin Releasing Factor
- COVID-19
- covid-19
- COVID-19 chemicals
- COVID-19 compounds
- COX-1 - Analgesics
- CPI-203
- cryptotanshinone
- CYP17A1 Inhibitors
- cyproconazole
- D-amino Acid Oxidase - Antidepressant
- D-amino Acid Oxidase - Antipsychotic
- D1 Receptors - Analgesics
- D1 Receptors - Anesthetic
- D1 Receptors - Antidepressant
- D1 Receptors - Antipsychotic
- D1 Receptors - Anxiolytic
- D1 Receptors - Cognition Enhancing
- D1 Receptors - Neurodegenerative Diseases
- D1 Receptors - Sedatives
- D2 Receptor Antagonists
- D2 Receptors - Analgesics
- D2 Receptors - Anesthetic
- D2 Receptors - Antidepressant
- D2 Receptors - Antipsychotic
- D2 Receptors - Anxiolytic
- D2 Receptors - Cognition Enhancing
- D2 Receptors - Neurodegenerative Diseases
- D2 Receptors - Sedatives
- D3 Receptors - Analgesics
- D3 Receptors - Antidepressant
- D3 Receptors - Antipsychotic
- D3 Receptors - Anxiolytic
- D3 Receptors - Cognition Enhancing
- D3 Receptors - Neurodegenerative Diseases
- D3 Receptors - Sedatives
- D4 Receptors - Analgesics
- D4 Receptors - Antidepressant
- D4 Receptors - Antipsychotic
- D4 Receptors - Anxiolytic
- D4 Receptors - Cognition Enhancing
- D4 Receptors - Neurodegenerative Diseases
- D4 Receptors - Sedatives
- D5 Receptors - Antidepressant
- D5 Receptors - Antipsychotic
- D5 Receptors - Anxiolytic
- D5 Receptors - Cognition Enhancing
- D5 Receptors - Sedatives
- DA Receptor Signaling - Analgesics
- DA Receptor Signaling - Anesthetic
- DA Receptor Signaling - Antidepressant
- DA Receptor Signaling - Antipsychotic
- DA Receptor Signaling - Anxiolytic
- DA Receptor Signaling - Cognition Enhancing
- DA Receptor Signaling - Neurodegenerative Diseases
- DA Receptor Signaling - Sedatives
- dactylosporangium
- DAT - Antidepressant
- deferiprone
- dextromethorphan
- Dietary Supplements
- dipropyl disulfide
- dipropyl sulfide
- DNA Polymerase
- DNA-PK
- docetaxel impurity B
- dopamine agonists
- Dopamine Receptor Inhibitors
- dopaminergic neurons
- dorsomorphin
- DOT1L Histone Methyltransferase
- DPP-4 Inhibitors
- eidd-1931
- EIDD-2801
- EIDD2801
- Endothelin Receptor Antagonists
- Entacapone
- epCAM
- ephR
- epicatechin
- epicatechin gallate
- epigallocatechin
- epigallocatechin gallate
- Epigenetic Modifiers
- Epinephrine/NE Agonists
- epoxiconazole
- Estrogen Receptor Inhibitors
- etoposide
- eukaryotic initiation factor (PERK)
- Fast Skeletal Muscle Troponin Complex - Neurodegenerative Diseases
- Furans - Anti-parasitic
- GABA - Antidepressant
- GABA - Antiepileptics and Anticonvulsants
- GABA - Antipsychotic
- Gastric Inhibitory Peptide
- Gastrin-releasing Peptide
- GBR-12935
- GDC-0941
- Ginkgolides and other Ginkgo-related Compounds
- Ginsenosides and Other Ginseng-related Compounds
- glimepiride
- glimepiride
- GLP
- GLP-1 Agonists
- Glucocorticoids - Other Therapies
- glycopeptides
- gossypol
- GpIIb/IIIa
- Gpr35
- grazoprevir
- grouped
- Haloperidol
- heparin
- hesperidin
- HEXIM1
- HIF-1
- Histamine Receptors - Analgesics
- Histamine Receptors - Antidepressant
- Histamine Receptors - Antipsychotic
- Histamine Receptors - Anxiolytic
- Histamine Receptors - Cognition Enhancing
- Histamine Receptors - Hypnotics
- Histamine Receptors - Neurodegenerative Diseases
- Histamine Receptors - Sedatives
- Hormone Receptor Modulators
- HSP70
- HSP90
- huperzine
- Hypnotics
- hypoerphosphorylated tau
- Hypothalamic-Pituitary Hormones
- hypoxia
- IAP
- ifenprodil
- IGF-1R
- Imidazoline Receptors - Analgesics
- Imidazoline Receptors - Antipsychotic
- Imidazoline Receptors - Cognition Enhancing
- Imidazoline Receptors - Neurodegenerative Diseases
- Imidazoline Receptors - Sedatives
- Immunosuppressive
- IMPDH
- Ion channels - Antidepressant
- Ion Channels - Antiepileptics and Anticonvulsants
- Ion Channels - Antipsychotic
- Ion Channels - Hypnotics
- ionophores
- ITF-2357
- JQ-1
- JQ-1
- K+ ATP Channel Blockers
- K+ Channels - Antidepressant
- K+ Channels - Antiepileptics and Anticonvulsants
- K+ Channels - Antipsychotic
- K+ Channels - Hypnotics
- KNL1
- ledipasvir
- Leptin Agonists
- Leukotriene Receptor Antagonists
- Lipotropin Agonists
- Lipoxygenase - Analgesics
- Lisinopril
- LMK-235
- lmk235
- Lopinavir
- loxapine
- LOXO-195
- loxo195
- lx2343
- M2 Protein Inhibitors
- mAChR - Antidepressant
- mAChR - Antipsychotic
- mAChR - Hypnotics
- Macrolides - Anti-parasitic
- Madagascar periwinkle
- MAO - Antidepressant
- MAO - Antiepileptics and Anticonvulsants
- maprotiline
- Melatonin Receptors - Analgesics
- Melatonin Receptors - Antidepressant
- Melatonin Receptors - Anxiolytic
- Melatonin Receptors - Hypnotics
- Melatonin Receptors - Neurodegenerative Diseases
- Melatonin Receptors - Sedatives
- Metabolic and GI Pathology
- methylprednisolone
- mGluR - Antiepileptics and Anticonvulsants
- Microtubule Polymerization/Depolymerization Inhibitors
- molnupiravir
- Muscarininc Acetylcholine Receptor Inhibitors
- Mycophenolic Acid
- mycophenolic acid
- Na+ Channels - Antidepressant
- Na+ Channels - Antiepileptics and Anticonvulsants
- Na+ Channels - Antipsychotic
- nAChR - Antidepressant
- nAChR - Antiepileptics and Anticonvulsants
- nanoparticle
- nanostructure lipid carrier
- Naphthoquinone
- Natural Products
- NET - Antidepressant
- NET - Antipsychotic
- NET - Hypnotics
- Neuroprotective
- New Products
- Nitroimidazoles - Anti-parasitic
- NKCC1 Inhibitors (Loop Diuretics)
- NMDA - Antidepressant
- NMDA - Antiepileptics and Anticonvulsants
- NMDA - Antipsychotic
- NMDA Receptors - Neurodegenerative Diseases
- NSAIDs: COX-1 Inhibitors
- olanzapine
- olaparib
- olopatadine
- omeprazole
- ophiobolin A
- Opioid Peptide Agonists
- Opioid Receptor Agonists
- Opioid Receptor Antagonists
- Opioid Receptors - Analgesics
- Opioid Receptors - Anesthetic
- Opioid Receptors - Antidepressant
- Opioid Receptors - Antiepileptics and Anticonvulsants
- Opioid Receptors - Anxiolytic
- Opioid Receptors - Cognition Enhancing
- Opioid Receptors - Neurodegenerative Diseases
- Opioid Receptors - Sedatives
- Orexin Receptors - Sedatives
- Organosulfurs - Anti-parasitic
- Other Compounds
- Other DA Signaling - Antidepressant
- Other DA Signaling - Antipsychotic
- Other Ion Channels - Antidepressant
- Other Ion Channels - Antiepileptics and Anticonvulsants
- Other Ion Channels - Antipsychotic
- Other Lipid-lowering Compounds
- Other Products
- Other Therapies
- OTX-015
- oxaliplatin
- oxcarbazepine
- oxidopamine
- p110
- p110alpha
- P2Y12
- p38 MAPK
- p53
- paclitaxel
- PAK4
- palmatine
- Pancreatic Polypeptide
- Parathyroid Hormone Agonists
- parkinson's
- Parkinson's Disease
- PARP
- parthenolide
- PDE
- PDGFR
- PDK1
- pemetrexed
- penicillins
- pentoxifylline
- Peptide Neurotransmitters
- peptide YY
- Peptides
- PERK
- Pesticides
- Pevonedistat
- PF-07321332
- Pharmaceutical Impurities and Derivatives
- Pharmaceutical Impurities and Derivatives
- Phytoestrogens
- phytosterol
- PI3K
- Pictrelisib
- PIK-294
- PIK-93
- Pim-1
- Pim1
- pioglitazone
- Piperazines
- PKA
- PKC
- PKC412
- Platinum-based Agents
- PLK
- polyenes
- polymixins
- polyphenol
- polysulfide
- Ponatinib
- ponatinib
- PORCUPINE
- PPAR Agonists
- PPAR Agonists (Fibrates)
- PPAR-a Agonists
- PPAR-y Agonists
- prednisolone
- prednisone
- prednisone acetate
- prexasertib
- pristimerin
- Profens
- progeria
- Progesterone
- Progestins
- Progestogens/Progestins
- Prolactin-releasing Peptide Agonists
- Prolyl Oligopeptidase - Neurodegenerative Diseases
- Promotion
- Propionic Acid Derivatives
- propofol
- Prostaglandin D Synthase Inhibitors
- Prostaglandin Synthetase - Analgesics
- Protease Inhibitors
- proteasome
- Protein Arginine Methyltransferase
- Protein synthesis Inhibitors
- Proton Pump Inhibitors
- PTEFb
- Purine derivatives
- purvalanol
- Pyrazolidines
- Rac1
- RAD51
- Rapamycin
- rapamycin
- rated-1
- Reprogramming
- Reverse Transcriptase Inhibitors
- rifampicin
- RIP
- RN-1734
- RNA Polymerase
- ROS1
- Sapanisertib
- SB-431542
- Sedatives and Hypnotics
- ser910
- Serotonin (5-HT3) Receptor Inhibitors
- Serotonin Receptors - Analgesics
- Serotonin Receptors - Antidepressant
- Serotonin Receptors - Antipsychotic
- Serotonin Receptors - Anxiolytic
- Serotonin Receptors - Cognition Enhancing
- Serotonin Receptors - Hypnotics
- Serotonin Receptors - Neurodegenerative Diseases
- Serotonin Receptors - Sedatives
- SERT - Antidepressant
- SERT - Antipsychotic
- SERT - Hypnotics
- sesterterpenoid
- Sigma Receptors - Antidepressant
- Sigma Receptors - Antiepileptics and Anticonvulsants
- Sigma Receptors - Antipsychotic
- Sigma Receptors - Anxiolytic
- Sigma Receptors - Cognition Enhancing
- Sigma Receptors - Neurodegenerative Diseases
- Sigma Receptors - Sedatives
- simeprevir
- simple
- SRp75
- staurosporine
- streptogramins
- su9516
- synephrine
- T315i
- TAK-931
- terpene
- Tetracyclines - Anti-parasitic
- Tetrahydropyrimidines
- Therapies for Respiratory Diseases and Allergy Management
- Thromboxane Receptor Antagonists
- Thymopoietin/Thymopentin Agonists
- Thyrotropin-RH
- tipranavir
- Top Menu
- TOPK
- Topoisomerase
- Topoisomerase Inhibitors
- Transcription Factor Modifiers
- Triple-negative breast cancer
- triterpene
- triterpenoid
- Trk Receptors - Cognition Enhancing
- Trk Receptors - Neurodegenerative Diseases
- TRP Channels - Analgesics
- TRP Channels - Anesthetic
- TRP Channels - Antidepressant
- TRP Channels - Antiepileptics and Anticonvulsants
- TRP Channels - Antipsychotic
- TRP Channels - Anxiolytic
- TRP Channels - Cognition Enhancing
- TRP Channels - Neurodegenerative Diseases
- TRP Channels - Sedatives
- TRPV4
- tryptophan
- TTK/Mps
- UNC0064-12
- uprosertib
- USP40 Taxol Impurities - Cell Fermentation
- USP40 Taxol Impurities - Isolated
- USP40 Taxol Impurities - Semisynthetic
- Valproic acid
- Vasopressin Agonists
- VE821
- velpatasvir
- vinpocetine
- VIP Agonists
- wc_update_product_lookup_tables
- Website Updates
- woocommerce-db-updates
- α1-adrenergic Receptor Antagonists - Antihypertensive
- α1-adrenergic Receptor Antagonists - Vasodilatory
- α2-adrenergic Receptor Agonists
- β Cell Proliferation Activator
Product Matches
Product ID
Name
Description
Purity
- Six New Products for the New YearLKT Labs continues to expand its catalog with six new compounds for the new year...
- Oxytocin Innovations and an FDA-approved Peptide DatabasePeptides and proteins as therapeutics have the advantage over other drugs of usi...
- Catalog RequestThe 2016-18 LKT Labs catalog contains close to 3,000 small molecules and peptide...
- Product FlyersBelow are many of the promotional flyers, you can select the one you want or you...
- Terms and ConditionsLKT Laboratories Inc. is focused on the production and distribution of high puri...
- Bulk Quote RequestLKT Labs offers discounting for bulk orders. We frequently provide small molecul...